FIC20200047I1 - Indakateroliasetaatti tai indakateroliksinafoaatti yhdessä mometasonifuroaatin kanssa, edullisesti indakateroliasetaatti yhdessä mometasonifuroaatin kanssa - Google Patents
Indakateroliasetaatti tai indakateroliksinafoaatti yhdessä mometasonifuroaatin kanssa, edullisesti indakateroliasetaatti yhdessä mometasonifuroaatin kanssaInfo
- Publication number
- FIC20200047I1 FIC20200047I1 FIC20200047C FIC20200047C FIC20200047I1 FI C20200047 I1 FIC20200047 I1 FI C20200047I1 FI C20200047 C FIC20200047 C FI C20200047C FI C20200047 C FIC20200047 C FI C20200047C FI C20200047 I1 FIC20200047 I1 FI C20200047I1
- Authority
- FI
- Finland
- Prior art keywords
- indacaterol
- combination
- mometasone furoate
- acetate
- xinafoate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0613158A GB0613158D0 (en) | 2006-06-30 | 2006-06-30 | Organic compounds |
| GB0613159A GB0613159D0 (en) | 2006-06-30 | 2006-06-30 | Organic Compounds |
| GB0613156A GB0613156D0 (en) | 2006-06-30 | 2006-06-30 | Organic Compounds |
| GB0613160A GB0613160D0 (en) | 2006-06-30 | 2006-06-30 | Organic Compounds |
| EP06117129A EP1878722A1 (en) | 2006-07-13 | 2006-07-13 | Quinolinone derivatives and their pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FIC20200047I1 true FIC20200047I1 (fi) | 2020-11-27 |
Family
ID=38610531
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIC20200047C FIC20200047I1 (fi) | 2006-06-30 | 2020-11-27 | Indakateroliasetaatti tai indakateroliksinafoaatti yhdessä mometasonifuroaatin kanssa, edullisesti indakateroliasetaatti yhdessä mometasonifuroaatin kanssa |
| FIC20200050C FIC20200050I1 (fi) | 2006-06-30 | 2020-12-16 | indakateroliasetaatti tai indakateroliksinafoaatti, edullisesti indakateroliasetaatti yhdessä mometasonifuroaatin ja glykopyrroniumin kanssa |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIC20200050C FIC20200050I1 (fi) | 2006-06-30 | 2020-12-16 | indakateroliasetaatti tai indakateroliksinafoaatti, edullisesti indakateroliasetaatti yhdessä mometasonifuroaatin ja glykopyrroniumin kanssa |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US8198450B2 (enExample) |
| EP (1) | EP2044025B1 (enExample) |
| JP (1) | JP5253392B2 (enExample) |
| KR (1) | KR101402398B1 (enExample) |
| CN (1) | CN101479245B (enExample) |
| AU (1) | AU2007264946B2 (enExample) |
| BE (2) | BE2020C550I2 (enExample) |
| BR (1) | BRPI0713951B8 (enExample) |
| CA (1) | CA2654801C (enExample) |
| CY (3) | CY1113733T1 (enExample) |
| DK (1) | DK2044025T3 (enExample) |
| ES (1) | ES2396987T3 (enExample) |
| FI (2) | FIC20200047I1 (enExample) |
| FR (2) | FR20C1054I1 (enExample) |
| HR (1) | HRP20121074T1 (enExample) |
| HU (2) | HUS2000043I1 (enExample) |
| IL (1) | IL195796A (enExample) |
| LT (2) | LTC2044025I2 (enExample) |
| LU (2) | LUC00185I2 (enExample) |
| MA (1) | MA30540B1 (enExample) |
| MX (1) | MX2008016542A (enExample) |
| MY (1) | MY150468A (enExample) |
| NO (3) | NO341709B1 (enExample) |
| NZ (1) | NZ573292A (enExample) |
| PL (1) | PL2044025T3 (enExample) |
| PT (1) | PT2044025E (enExample) |
| SI (1) | SI2044025T1 (enExample) |
| WO (1) | WO2008000839A1 (enExample) |
| ZA (1) | ZA200809948B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2298900A1 (en) | 1996-09-17 | 2011-03-23 | Novartis Vaccines and Diagnostics, Inc. | Compositions and methods for treating intracellular diseases |
| ES2452965T3 (es) | 2007-09-05 | 2014-04-03 | Rigel Pharmaceuticals, Inc. | Sal de xinafoato de N4-[(2,2-difluoro-4H-benzo[1,4]oxazin-3-ona)-6-il]-5-fluoro-N2-[3-(metilaminocarbonilmetilenoxi)fenil]-2,4-pirimidindiamina |
| JOP20120023B1 (ar) | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
| US9452139B2 (en) | 2013-03-14 | 2016-09-27 | Novartis Ag | Respirable agglomerates of porous carrier particles and micronized drug |
| WO2014141069A1 (en) | 2013-03-14 | 2014-09-18 | Novartis Ag | Deamorphization of spray-dried formulations via spray-blending |
| ES2747905T3 (es) | 2015-09-29 | 2020-03-12 | Inke Sa | Solvato mixto de L-tartrato de (R)-5-[2-(5,6-dietilindan-2-ilamino)-1-hidroxietil]-8-hidroxi-1H-quinolin-2-ona |
| CN110724095B (zh) * | 2019-09-12 | 2023-06-09 | 上海方予健康医药科技有限公司 | 一种茚达特罗乙酸盐的制备方法 |
| WO2026027448A1 (en) | 2024-07-29 | 2026-02-05 | Inke, S.A. | Micronization process of indacaterol acetate |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05202301A (ja) * | 1991-08-29 | 1993-08-10 | Yamamoto Chem Inc | ２−アニリノ−３−メチル−６−（Ｎ−ｎ−ブチル−Ｎ−シクロヘキシルアミノ）フルオランの結晶変態、その製造方法及びこの結晶変態を含有する記録材料 |
| EP0688871A3 (en) * | 1994-06-24 | 1998-07-08 | Quest International B.V. | Preparation of phytosphingosine derivative |
| FR2777279B1 (fr) * | 1998-04-08 | 2004-08-13 | Hoechst Marion Roussel Inc | Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide |
| GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| GB0029562D0 (en) * | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
| GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
| GB0127430D0 (en) | 2001-11-15 | 2002-01-09 | Smithkline Beecham Corp | Compounds |
| US7417051B2 (en) | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
| US7250426B2 (en) | 2002-11-29 | 2007-07-31 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Tiotropium-containing pharmaceutical combination for inhalation |
| GB0303910D0 (en) | 2003-02-20 | 2003-03-26 | Merck Sharp & Dohme | Therapeutic agents |
| TWI324150B (en) | 2003-02-28 | 2010-05-01 | Novartis Ag | Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt |
| TWI324151B (en) | 2003-04-02 | 2010-05-01 | Novartis Ag | Process for the preparation of 5-(haloacetyl)-8-substituted oxy-(1h)-quinolin-2-ones |
| ATE421322T1 (de) | 2003-04-04 | 2009-02-15 | Novartis Pharma Gmbh | Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege |
| JP2005343889A (ja) | 2004-05-06 | 2005-12-15 | Taisho Pharmaceut Co Ltd | イミダゾピリジン誘導体 |
| GB0411056D0 (en) * | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| GB0413960D0 (en) | 2004-06-22 | 2004-07-28 | Novartis Ag | Organic compounds |
| CN101142217B (zh) | 2005-03-21 | 2010-12-08 | 伊莱利利公司 | 咪唑并哒嗪化合物 |
| GB0511065D0 (en) * | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
| US20100216798A1 (en) | 2005-07-29 | 2010-08-26 | Astellas Pharma Inc | Fused heterocycles as lck inhibitors |
-
2007
- 2007-07-02 US US12/304,617 patent/US8198450B2/en active Active
- 2007-07-02 CA CA2654801A patent/CA2654801C/en active Active
- 2007-07-02 KR KR1020087031819A patent/KR101402398B1/ko active Active
- 2007-07-02 PL PL07819899T patent/PL2044025T3/pl unknown
- 2007-07-02 PT PT78198991T patent/PT2044025E/pt unknown
- 2007-07-02 SI SI200731103T patent/SI2044025T1/sl unknown
- 2007-07-02 JP JP2009517241A patent/JP5253392B2/ja active Active
- 2007-07-02 CN CN2007800244042A patent/CN101479245B/zh active Active
- 2007-07-02 WO PCT/EP2007/056632 patent/WO2008000839A1/en not_active Ceased
- 2007-07-02 NZ NZ573292A patent/NZ573292A/en unknown
- 2007-07-02 EP EP07819899A patent/EP2044025B1/en active Active
- 2007-07-02 DK DK07819899.1T patent/DK2044025T3/da active
- 2007-07-02 MX MX2008016542A patent/MX2008016542A/es active IP Right Grant
- 2007-07-02 ES ES07819899T patent/ES2396987T3/es active Active
- 2007-07-02 BR BRPI0713951A patent/BRPI0713951B8/pt active IP Right Grant
- 2007-07-02 MY MYPI20085146 patent/MY150468A/en unknown
- 2007-07-02 AU AU2007264946A patent/AU2007264946B2/en active Active
- 2007-07-02 HR HRP20121074TT patent/HRP20121074T1/hr unknown
-
2008
- 2008-11-24 ZA ZA2008/09948A patent/ZA200809948B/en unknown
- 2008-12-08 IL IL195796A patent/IL195796A/en active IP Right Grant
- 2008-12-30 MA MA31527A patent/MA30540B1/fr unknown
-
2009
- 2009-01-20 NO NO20090312A patent/NO341709B1/no active Protection Beyond IP Right Term
-
2012
- 2012-05-04 US US13/463,978 patent/US20120316142A1/en not_active Abandoned
- 2012-11-29 CY CY20121101169T patent/CY1113733T1/el unknown
-
2020
- 2020-11-12 FR FR20C1054C patent/FR20C1054I1/fr active Active
- 2020-11-18 HU HUS2000043C patent/HUS2000043I1/hu unknown
- 2020-11-20 LU LU00185C patent/LUC00185I2/fr unknown
- 2020-11-23 NO NO2020041C patent/NO2020041I1/no unknown
- 2020-11-25 LT LTPA2020535C patent/LTC2044025I2/lt unknown
- 2020-11-25 BE BE2020C550C patent/BE2020C550I2/nl unknown
- 2020-11-26 CY CY2020038C patent/CY2020038I2/el unknown
- 2020-11-27 FI FIC20200047C patent/FIC20200047I1/fi unknown
- 2020-12-07 NO NO2020044C patent/NO2020044I1/no unknown
- 2020-12-07 LU LU00188C patent/LUC00188I2/en unknown
- 2020-12-08 FR FR20C1063C patent/FR20C1063I1/fr active Active
- 2020-12-09 HU HUS2000053C patent/HUS2000053I1/hu unknown
- 2020-12-14 CY CY2020041C patent/CY2020041I1/el unknown
- 2020-12-16 FI FIC20200050C patent/FIC20200050I1/fi unknown
- 2020-12-16 BE BE2020C552C patent/BE2020C552I2/nl unknown
- 2020-12-16 LT LTPA2020538C patent/LTPA2020538I1/lt unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20200050I1 (fi) | indakateroliasetaatti tai indakateroliksinafoaatti, edullisesti indakateroliasetaatti yhdessä mometasonifuroaatin ja glykopyrroniumin kanssa | |
| NL2000690A1 (nl) | Gestabiliseerde farmaceutische samenstellingen omvattende fesoterodine. | |
| BRPI0718688A2 (pt) | Composições de baixa irritação e métodos para preparar as mesmas. | |
| PL2271725T3 (pl) | Kompozycje zawierające 2,3,3,3-tetrafluoropropen i 1,1,1-trifluoropropen | |
| IL219268A (en) | Anti-b79cd antibody, immunosuppressant and pharmacological agent that includes and uses it | |
| BRPI0920980A2 (pt) | saída para gás. | |
| PL2899247T3 (pl) | Kompozycje zawierające 2,3,3,3-tetrafluoropropen i węglowodory oraz ich zastosowania | |
| IL212836A0 (en) | Azaquinolinone derivatives, compositions comprising the same and uses thereof | |
| IL220283A0 (en) | 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof | |
| EP2396036A4 (en) | IMMUNOKONJUGATE WITH INTRA-CELLULAR CREMABLE COMPOUND | |
| SI1998783T1 (sl) | Oftalmični sestavki, ki obsegajo providon-jod | |
| BRPI0915299A2 (pt) | poliamida, composição compreendendo tal poliamida e utilização das mesmas | |
| IL216014A0 (en) | Antibodies immunorective with heregulin-her3 complexes, compositions comprising the same and uses thereof | |
| IL212278A0 (en) | Morpholinopurine derivatives, compositions comprising the same and uses thereof | |
| IL206808A (en) | Indolyl-pyridone history, their pharmaceutical preparations and their uses | |
| FR2946255B1 (fr) | Composition comprenant du trans-cinnamaldehyde | |
| IL213043A0 (en) | Lantibiotic carboxyamide derivatives, compositions comprising the same and uses thereof | |
| FR2900034B1 (fr) | Poudrier. | |
| BRPI0809684A2 (pt) | Embalagem, e embalagem | |
| DE502008001037D1 (de) | AUSGIEßER | |
| IL216828A0 (en) | Styryl-triazine derivatives, compositions comprising the same and uses thereof | |
| DK1886686T3 (da) | Farmaceutisk sammensætning indeholdende mometasonfuroat | |
| FI20075086L (fi) | Aromikoostumus | |
| IL208168A0 (en) | Tetrahydroisoquinoline derivatives, compositions comprising the same and use thereof | |
| PL1927646T3 (pl) | Środek nawaniający o polepszonej trwałości |